117 related articles for article (PubMed ID: 16873075)
1. TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7).
Reuss A; du Bois A; Harter P; Fotopoulou C; Sehouli J; Aletti G; Guyon F; Greggi S; Mosgaard BJ; Reinthaller A; Hilpert F; Schade-Brittinger C; Chi DS; Mahner S
Int J Gynecol Cancer; 2019 Oct; 29(8):1327-1331. PubMed ID: 31420412
[TBL] [Abstract][Full Text] [Related]
2. Advanced ovarian yolk sac tumor: upfront surgery or neoadjuvant chemotherapy followed by interval debulking?
Zhang X; Yang J; Xiang Y; Pan L; Wu M; Cao D; Yang J
Int J Gynecol Cancer; 2023 Sep; ():. PubMed ID: 37696647
[TBL] [Abstract][Full Text] [Related]
3. Surgical debulking of ovarian cancer: what difference does it make?
Schorge JO; McCann C; Del Carmen MG
Rev Obstet Gynecol; 2010; 3(3):111-7. PubMed ID: 21364862
[TBL] [Abstract][Full Text] [Related]
4. ASO Visual Abstract: Expanding the Use of HIPEC in Ovarian Cancer at the Time of Interval Debulking Surgery to FIGO Stage IV After Six Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis of Perioperative and Oncologic Outcomes.
Ghirardi V; Trozzi R; Scanu FR; Giannarelli D; Santullo F; Costantini B; Naldini A; Panico C; Frassanito L; Scambia G; Fagotti A
Ann Surg Oncol; 2024 Mar; ():. PubMed ID: 38556598
[No Abstract] [Full Text] [Related]
5. Correspondence on "Expanding the Use of HIPEC in Ovarian Cancer at Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis and Perioperative and Oncologic Outcomes" by Valentina Ghirardi et al.
Ray M; Solomi VC
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38704500
[No Abstract] [Full Text] [Related]
6. Author's reply to correspondence on "Expanding the Use of HIPEC in Ovarian Cancer at Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis and Perioperative and Oncologic Outcomes" by Mukurdipi Ray et al.
Ghirardi V; Trozzi R; Scambia G; Fagotti A
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38814550
[No Abstract] [Full Text] [Related]
7. Extra cycles of neoadjuvant chemotherapy before interval surgery for ovarian cancer: the more the merrier or too much of a good thing?
Nitecki R; Melamed A
Int J Gynecol Cancer; 2022 Jul; ():. PubMed ID: 35858713
[No Abstract] [Full Text] [Related]
8. Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals.
Muñoz-Casares FC; Rufián S; Rubio MJ; Lizárraga E; Díaz-Iglesias C; Aranda E; Ciria R; Muntané J; Barrios P; Torres-Melero J; González-Moreno S; González-Bayón L; Camps B; Bretcha P; Farré J; Ortega-Pérez G; Gómez-Portilla A
Clin Transl Oncol; 2007 Oct; 9(10):652-62. PubMed ID: 17974526
[TBL] [Abstract][Full Text] [Related]
9. The position of neoadjuvant chemotherapy within the treatment of ovarian cancer.
Van Gorp T; Amant F; Neven P; Berteloot P; Leunen K; Vergote I
Minerva Ginecol; 2006 Oct; 58(5):393-403. PubMed ID: 17006426
[TBL] [Abstract][Full Text] [Related]
10. [Neoadjuvant chemotherapy and ovarian cancer].
Ray-Coquard I; Saba C; Bachelot T; Méeus P; Mignotte H; Blondet R; Treilleux I; Peix M; Guastalla JP
Bull Cancer; 2006 Jul; 93(7):669-76. PubMed ID: 16873075
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant chemotherapy for advanced epithelial ovarian cancer].
Hatae M; Onishi Y; Nakamura T; Yamamoto H; Kusumoto M; Matsui T; Mihara K; Taniguchi H
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1833-7. PubMed ID: 11729475
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.
Vergote IB; De Wever I; Decloedt J; Tjalma W; Van Gramberen M; van Dam P
Semin Oncol; 2000 Jun; 27(3 Suppl 7):31-6. PubMed ID: 10952124
[TBL] [Abstract][Full Text] [Related]
13. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
[TBL] [Abstract][Full Text] [Related]
14. [Neo-adjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer treatment--a retrospective study].
Tkácová M; Vertaková-Krakovská B; Belohorská B; Miskovská V; Helpianska L; Ondrus D; Ondrusová M; Spánik S; Svec J
Klin Onkol; 2009; 22(6):273-7. PubMed ID: 20099745
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
